Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Murad Abusamra"'
Autor:
Philipp Backhaus, Keith S. Pentlow, Alan L Ho, Audrey Mauguen, James A Fagin, Naga Vara Kishore Pillarsetty, Serge K. Lyashchenko, Eva Burnazi, Ronald A. Ghossein, Shalini Chhabra, Murad Abusamra, Steven M. Larson, Heiko Schöder, Joseph O’Donoghue, Wolfgang Weber, Ravinder K. Grewal
Publikováno v:
EJNMMI Research, Vol 14, Iss 1, Pp 1-9 (2024)
Abstract Background Fluorine 18-labelled tetrafluoroborate ([18F]TFB) is a substrate for the sodium/iodide symporter. In thyroid cancer, [18F]TFB-PET/CT may be an alternative to iodine imaging to evaluate the extent of disease, eligibility for radioi
Externí odkaz:
https://doaj.org/article/478716ece8d34d68925bb38dff772cb6
Autor:
Audrey Mauguen, Ravinder K. Grewal, Finn Augensen, Murad Abusamra, Sonia Mahajan, Vetri Sudar Jayaprakasam, Joseph Osborne, Sofia Haque, Bernadette Z. Y. Wong, Ronald A. Ghossein, James Fagin, Heiko Schӧder, R. Michael Tuttle, Alan Ho, John L. Humm, Steven M. Larson
Publikováno v:
European Journal of Nuclear Medicine and Molecular Imaging.
Purpose To introduce a biomarker-based dosimetry method for the rational selection of a treatment activity for patients undergoing radioactive iodine 131I therapy (RAI) for metastatic differentiated thyroid cancer (mDTC) based on single-timepoint ima
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4b458e6ce41d57ae037f4c8d4be638a6
https://doi.org/10.1007/s00259-023-06240-1
https://doi.org/10.1007/s00259-023-06240-1
Autor:
Audrey Mauguen, Ravinder Grewal, Finn Augensen, Murad Abusamra, Sonia Mahajan, Vetri Sudar Jayaprakasam, Joseph Osborne, Keith Pentlow, Sofia Haque, James Fagin, Heiko Schoder, Michael Tuttle, Alan Ho, John Humm, Steven Larson
Purpose To introduce a biomarker-based dosimetry method for radioactive iodine 131I therapy (RAI) of metastatic differentiated thyroid cancer (mDTC), adapted to the underlying heterogeneity of lesions’ radiation-absorbed dose (RAD) in cGy, and perm
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8075560795ff592a2316a4bcb4c32da9
https://doi.org/10.21203/rs.3.rs-2156223/v1
https://doi.org/10.21203/rs.3.rs-2156223/v1
Autor:
Mina Meseha, Murad Abusamra, Azeez Farooki, Andriy Derkach, Kylee Maclachlan, Malin Hultcrantz, Hani Hassoun, Urvi Shah, Sydney Lu, Sham Mailankody, Dhwani Patel, Oscar Lahoud, Gunjan Shah, Michael Scordo, David Chung, Heather Landau, Alexander Lesokhin, Neha Korde, Sergio Giralt, Saad Usmani, Carlyn Tan
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 22:S139-S140
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6b4306247cf763e9771c381509a0e86f
https://doi.org/10.1016/s2152-2650(22)00520-1
https://doi.org/10.1016/s2152-2650(22)00520-1
Publikováno v:
ICMHI
Achieving the optimal enhancement is the desired goal of any computed tomography (CT) scan with intravenous (IV) contrast medium (CM). The aim of this study is to assess IV timing and other CM related factors when different enhancement phases were us
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9342c32460f837465568edb05e0d8a5c
https://doi.org/10.1145/3418094.3418138
https://doi.org/10.1145/3418094.3418138